Search hospitals
>
Georgia
>
Atlanta
Emory University
Claim this profile
Atlanta, Georgia 30322
Global Leader in Cancer
Global Leader in Heart Failure
Conducts research for Stroke
Conducts research for Coronary Artery Disease
Conducts research for Cardiovascular Disease
1257 reported clinical trials
153 medical researchers
Summary
Emory University is a medical facility located in Atlanta, Georgia. This center is recognized for care of Cancer, Heart Failure, Stroke, Coronary Artery Disease, Cardiovascular Disease and other specialties. Emory University is involved with conducting 1,257 clinical trials across 1,610 conditions. There are 153 research doctors associated with this hospital, such as Conor Steuer, Olatunji Alese, Edmund Waller, MD, and Mehmet Bilen, MD.
Area of expertise
Cancer
Emory University has run 88 trials for Cancer. Some of their research focus areas include:
Heart Failure
Emory University has run 81 trials for Heart Failure. Some of their research focus areas include:
Top PIs
Conor Steuer
Emory University Hospital Midtown
1 year of reported clinical research
Olatunji Alese
Emory University Hospital/Winship Cancer Institute
8 years of reported clinical research
Edmund Waller, MD
Emory University Hospital
6 years of reported clinical research
Mehmet Bilen, MD
Emory University Hospital/Winship Cancer Institute
3 years of reported clinical research
Clinical Trials running at Emory University
Crohn's Disease
Ovarian Cancer
Multiple Myeloma
Breast Cancer
Colorectal Cancer
Polycystic Kidney Disease
Depression
Schizophrenia
Coronary Artery Disease
Vasculitis
Anti-TNF Therapy
for Crohn's Disease in Children
Crohn's disease (CD) is a condition that causes inflammation (swelling, redness) of the lining and wall of the small intestine, large intestine, or both. CD may be associated with abdominal cramps/pain, diarrhea, blood in the stool, weight loss, or delayed growth in children. While the exact cause of CD is not certain it is thought that the immune system located in the intestine reacts abnormally to the large number of bacteria contained there. The investigators think that diet, exposure to antibiotics early in life, and having a family history of CD puts people at increased risk for developing CD. In order to decrease the inflammation doctors use what is called biologic therapy with anti-TNF molecules that can be given through an intravenous or shots. TNF is a chemical made by white blood cells that is involved in inflammation. When this type of treatment is given early after diagnosis it is more effective than when it is given later. The investigators have learned that it is important to give the optimum (ideal) amount of this medicine guided by certain blood tests. The investigators also know that not everyone responds to this therapy but do not understand the reasons for this variability between people. The CAMEO study has been started to help understand what factors are important in determining whether a child with CD completely heals the inflammation after anti-TNF therapy. The investigators will do that by measuring certain markers of inflammation in the blood and stool and by looking at a person's genes (DNA) and how inflammation is controlled in the intestine. These inflammation tests will be done before, during, and after one year of anti-TNF therapy. The investigators will determine how much healing has taken place by comparing the results of the colonoscopy and a special type of MRI that are both done before anti-TNF and then again one year later. The goal in treating CD is to heal both the lining and the wall of the intestine. Children ages 6-17 years who are thought to have CD and are about to undergo their diagnostic colonoscopy are eligible to be enrolled. If they are found to indeed have CD and start an anti-TNF medicine within 6 months they can continue in the study. There are no increased risks of participating in this study beyond those normally associated with having CD and its treatment. By better understanding why the bowel does or does not heal, doctors will be better able to provide personalized care.
Recruiting
3 awards
Phase 4
7 criteria
Mirikizumab
for Pediatric Crohn's Disease
Study participants will be screened during the platform study and randomly assigned to receive mirikizumab or another intervention. The purpose of the mirikizumab study is to evaluate efficacy, safety, tolerability, and how well mirikizumab absorbs into the body of pediatric participants with Crohn's disease. Study periods for the intervention-specific appendix (ISA) will be as follows: * A 12-week induction period * A maintenance period from Week 12 to Week 52, and * A safety follow-up period up to 16 weeks. The study will last about 74 weeks and may include up to 19 visits.
Recruiting
2 awards
Phase 3
Guselkumab
for Pediatric Crohn's Disease
This trial tests guselkumab, an anti-inflammatory medication, on children with Crohn's Disease who initially responded well to it. The goal is to see if the benefits last over several months by reducing immune system activity. Guselkumab has shown effectiveness in treating moderate-to-severe psoriasis and psoriatic arthritis.
Recruiting
2 awards
Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Emory University?
Emory University is a medical facility located in Atlanta, Georgia. This center is recognized for care of Cancer, Heart Failure, Stroke, Coronary Artery Disease, Cardiovascular Disease and other specialties. Emory University is involved with conducting 1,257 clinical trials across 1,610 conditions. There are 153 research doctors associated with this hospital, such as Conor Steuer, Olatunji Alese, Edmund Waller, MD, and Mehmet Bilen, MD.
Where is Emory University located?
**Directions to Emory University Hospital Midtown, Atlanta, GA:** - From I-75/85 Northbound, continue on I-85 North to Clairmont Road, exit #91. - Follow signs to Decatur, drive 4-5 miles on Clairmont Road to North Decatur Road, then turn right. - Proceed one mile to Clifton Road, turn right, and the hospital is 100 yards on the left.
Who should I call to ask about financial aid or insurance network?
**Emory University Financial Assistance:** - For staff and faculty experiencing financial hardship, contact the Emory University Hardship Fund at hardship.fund@emory.edu or fax 404-712-1470. - For student insurance inquiries, reach out to the Emory University Student Health Insurance Plan (EUSHIP) at 404-727-7560. For other billing and insurance issues, call 404-727-8721. **Emory Healthcare Financial Assistance:** - Contact a Financial Counselor at (404) 778-7318 for insurance coverage review, out-of-pocket obligations, and financial coverage options. - Access the Emory Healthcare Financial Assistance Policy, Plain Language Summary, and Application Form on their website.
What insurance does Emory University accept?
Emory University accepts most major insurance plans, including private, employer-based, Federal health insurance marketplace plans, traditional Medicare, and Medicare Advantage plans. Employees of Emory University can choose from three medical plans: the Aetna HSA Plan, the Aetna POS Plan, and the Kaiser Permanente Plan. For detailed coverage information, contact your insurance carrier directly or call Emory Healthcare's information line at 404-778-7777 or 1-800-75-EMORY (1-800-753-6679).
What awards or recognition has Emory University received?
Emory University Hospital, located in Atlanta, Georgia, secured a record $894.7 million in research funding in fiscal year 2021, with $526 million coming from the National Institutes of Health (NIH). It was also chosen as the first recipient of a $24.8 million cooperative agreement from the Advanced Research Projects Agency for Health (ARPA-H), underscoring its role in pioneering biomedical and health research.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.